Skip to main content
Ascletis Pharma Inc. logo

Ascletis Pharma Inc. — Investor Relations & Filings

Ticker · 1672 ISIN · KYG0520K1094 LEI · 254900SKEFCO9I3GPL05 HKEX Manufacturing
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2021-10-27 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1672

About Ascletis Pharma Inc.

http://www.ascletis.com

Ascletis Pharma Inc. is a fully integrated, R&D driven biotechnology company dedicated to the development and commercialization of potential best-in-class and first-in-class therapeutics. The company covers the entire value chain from discovery to sales. Ascletis primarily focuses on metabolic diseases, including chronic weight management, utilizing proprietary platforms such as Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD), Ultra-Long-Acting Platform (ULAP), and Peptide Oral Transport ENhancement Technology (POTENT). Key pipeline candidates include ASC30 (oral/subcutaneous GLP-1R agonist), ASC35 (GLP-1R/GIPR dual agonist), ASC36 (amylin receptor agonist), and ASC37 (GLP-1R/GIPR/GCGR triple agonist). The company also maintains active programs in viral diseases, NASH/PBC, and oncology.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return (Equity issuer - changes in issued share capital and/or share buybacks)' and contains detailed information about share repurchases by Ascletis Pharma Inc. It includes dates, number of shares repurchased, prices, and confirmations related to compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on reporting share buybacks and changes in issued share capital, which aligns with the category of reporting transactions in own shares. The document is not an announcement of a report, nor is it a full financial report or management discussion. Therefore, the most appropriate classification is 'Transaction in Own Shares' (POS).
2021-10-27 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is a Next Day Disclosure Return related to changes in issued share capital and share buybacks for World Houseware (Holdings) Limited. It details the exercise of share options and changes in the number of issued shares, including confirmations by the company secretary. The content focuses on share capital changes and share buybacks, which aligns with announcements regarding share issues or capital changes. It is not a full financial report, earnings release, or management discussion. The document is about reporting changes in share capital and share buybacks, fitting the category of Share Issue/Capital Change (SHA). The document length (7195 characters) supports it being a substantive disclosure rather than a brief announcement or certification only.
2021-10-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Ascletis Pharma Inc. It includes detailed tables of repurchase transactions, dates, quantities, prices, and confirmations that these transactions comply with listing rules of the Stock Exchange of Hong Kong. The document is a regulatory disclosure about share repurchases and capital changes, not a financial report or earnings release. It is not an announcement of a report publication but a formal regulatory filing required by the exchange. Therefore, the document fits best under 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2021-10-26 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Ascletis Pharma Inc. It details repurchases of shares on various dates, quantities, and prices, confirming compliance with listing rules. The content focuses on share repurchase activities and changes in issued shares, with no financial statements or earnings data. This matches the definition of 'Transaction in Own Shares' filings, which report company buybacks or sales of its own shares. The document is substantive and not merely an announcement or certification, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2021-10-25 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return (Equity issuer - changes in issued share capital and/or share buybacks)' and details multiple repurchases of shares by Ascletis Pharma Inc. It includes specific dates, quantities of shares repurchased, prices paid, and confirmations that these repurchases comply with listing rules. The document is a regulatory disclosure related to share repurchases and changes in issued share capital, not a full financial report or earnings release. It is not an announcement of a report publication but a detailed disclosure of transactions. This fits the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback activities.
2021-10-22 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and/or share buybacks for World Houseware (Holdings) Limited. It details the exercise of share options, changes in issued shares, and confirmations related to share issuance compliance with listing rules. The content focuses on share capital changes and disclosures pursuant to stock exchange rules, specifically referencing share issues and repurchases. This matches the description of a Share Issue/Capital Change announcement rather than a full financial report or other categories. The document length is 7187 characters, which is substantive and contains detailed data on share capital changes, not merely an announcement of a report. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2021-10-21 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.